ISIN | LU1280185148 |
---|---|
Valor Number | 29323863 |
Bloomberg Global ID | |
Fund Name | MFS Meridian Funds - Global Equity Income Fund AH1 Acc |
Fund Provider |
MFS International Limited
London, United Kingdom Phone: +44 20 7429 7200 |
Fund Provider | MFS International Limited |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) |
Carnegie Fund Services S.A. Genève 11 Phone: +41 22 705 11 77 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The Fund’s investment objective is to seek total return through a combination of current income and capital appreciation, measured in US dollars. The Fund invests primarily (at least 70%) in equity securities of companies located in developed and emerging market countries. The Fund normally primarily invests in income-producing equity securities. The Fund invests the majority of its assets in dividend-paying common stocks, but may invest in other types of income producing securities, including convertible securities, preferred stocks and equity interests in closed-ended real estate investment trusts (REITs) or equity securities of companies principally engaged in the real estate industry. The Fund may also invest in non-income-producing equity securities. |
Peculiarities |
Current Price * | 15.97 EUR | 31.07.2025 |
---|---|---|
Previous Price * | 16.13 EUR | 30.07.2025 |
52 Week High * | 16.50 EUR | 23.07.2025 |
52 Week Low * | 13.89 EUR | 08.04.2025 |
NAV * | 15.97 EUR | 31.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 9,374,691 | |
Unit/Share Assets *** | 276,201 | |
Trading Information SIX |
YTD Performance | +6.18% |
31.12.2024 - 31.07.2025
31.12.2024 31.07.2025 |
---|---|---|
YTD Performance (in CHF) | +4.97% |
31.12.2024 - 31.07.2025
31.12.2024 31.07.2025 |
1 month | -1.11% |
30.06.2025 - 31.07.2025
30.06.2025 31.07.2025 |
3 months | +3.90% |
30.04.2025 - 31.07.2025
30.04.2025 31.07.2025 |
6 months | +4.31% |
31.01.2025 - 31.07.2025
31.01.2025 31.07.2025 |
1 year | +0.50% |
31.07.2024 - 31.07.2025
31.07.2024 31.07.2025 |
2 years | +13.58% |
31.07.2023 - 31.07.2025
31.07.2023 31.07.2025 |
3 years | +19.36% |
01.08.2022 - 31.07.2025
01.08.2022 31.07.2025 |
5 years | +44.39% |
03.08.2020 - 31.07.2025
03.08.2020 31.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 2.97% | |
---|---|---|
KDDI Corp | 2.93% | |
AbbVie Inc | 2.90% | |
Colgate-Palmolive Co | 2.89% | |
Kimberly-Clark Corp | 2.64% | |
Tesco PLC | 2.43% | |
Northern Trust Corp | 2.36% | |
Pfizer Inc | 2.33% | |
Compagnie de Saint-Gobain SA | 2.30% | |
China Construction Bank Corp Class H | 2.12% | |
Last data update | 30.06.2025 |
TER *** | 1.70% |
---|---|
TER date *** | 31.01.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.70% |
Ongoing Charges *** | 1.70% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |